A randomized phase 2a efficacy and safety trial of the topical J anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
Author:
Affiliation:
1. Pfizer Inc. Groton CT 06340 U.S.A
2. The University of Montreal Montreal QC Canada
3. Innovaderm Research Montreal QC Canada
4. Probity Medical ResearchWaterloo ON Canada
5. K. Papp Clinical Research Inc. Waterloo ON Canada
Publisher
Wiley
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.12266
Reference26 articles.
1. Canadian Guidelines for the Management of Plaque Psoriasis: Overview
2. New biologic drugs get under the skin of psoriasis
3. Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
4. Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
Cited by 182 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of topical tofacitinib in autoimmune skin disorders: An expert opinion;IP Indian Journal of Clinical and Experimental Dermatology;2024-09-15
2. Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis;International Journal of Nanomedicine;2024-07
3. Inhibition of the JAK-STAT Pathway in the Treatment of Psoriasis: A Review of the Literature;International Journal of Molecular Sciences;2024-04-25
4. Evaluating the Cost Burden of Alopecia Areata Treatment: A Comprehensive Review for Dermatologists;Cutis;2024-04-01
5. A Review on Nanosystem-Based Delivery of Tofacitinib for Enhanced Treatment of Autoimmune Diseases and Inflammation;BioNanoScience;2024-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3